É. Liozon

5.0k total citations
127 papers, 2.3k citations indexed

About

É. Liozon is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Genetics. According to data from OpenAlex, É. Liozon has authored 127 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Pulmonary and Respiratory Medicine, 52 papers in Rheumatology and 27 papers in Genetics. Recurrent topics in É. Liozon's work include Vasculitis and related conditions (72 papers), Otitis Media and Relapsing Polychondritis (21 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (20 papers). É. Liozon is often cited by papers focused on Vasculitis and related conditions (72 papers), Otitis Media and Relapsing Polychondritis (21 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (20 papers). É. Liozon collaborates with scholars based in France, United States and Switzerland. É. Liozon's co-authors include K.H. Ly, A.L. Fauchais, P. Soria, V. Loustaud, Hubert de Boysson, Elisabeth Vidal, Achille Aouba, Éric Vidal, F Liozon and Boris Bienvenu and has published in prestigious journals such as Blood, Annals of Internal Medicine and PLoS ONE.

In The Last Decade

É. Liozon

121 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
É. Liozon France 28 1.4k 1.1k 589 307 272 127 2.3k
Micki Klearman United States 17 1.1k 0.8× 1.8k 1.6× 587 1.0× 455 1.5× 200 0.7× 31 2.7k
Koichi Amano Japan 28 602 0.4× 1.4k 1.2× 524 0.9× 431 1.4× 370 1.4× 133 2.2k
Tomás R. Vázquez-Rodríguez Spain 23 848 0.6× 1.3k 1.1× 328 0.6× 152 0.5× 210 0.8× 52 2.1k
Katie Tuckwell United States 14 1.1k 0.8× 1.0k 0.9× 535 0.9× 140 0.5× 158 0.6× 35 1.6k
Sophie Dimonaco United Kingdom 11 861 0.6× 921 0.8× 396 0.7× 179 0.6× 107 0.4× 18 1.5k
Jolanta Dadonienė Lithuania 14 929 0.7× 716 0.6× 328 0.6× 102 0.3× 197 0.7× 50 1.5k
Maria J. Lopez‐Diaz Spain 14 1.3k 0.9× 1.1k 1.0× 450 0.8× 54 0.2× 135 0.5× 18 1.7k
Jiuliang Zhao China 24 751 0.5× 1.2k 1.1× 118 0.2× 234 0.8× 465 1.7× 231 2.3k
Jan Willem Cohen-Tervaert United Kingdom 7 1.9k 1.4× 931 0.8× 522 0.9× 49 0.2× 130 0.5× 8 2.1k
E Mirapeix Spain 11 1.8k 1.3× 756 0.7× 646 1.1× 60 0.2× 114 0.4× 27 2.0k

Countries citing papers authored by É. Liozon

Since Specialization
Citations

This map shows the geographic impact of É. Liozon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by É. Liozon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites É. Liozon more than expected).

Fields of papers citing papers by É. Liozon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by É. Liozon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by É. Liozon. The network helps show where É. Liozon may publish in the future.

Co-authorship network of co-authors of É. Liozon

This figure shows the co-authorship network connecting the top 25 collaborators of É. Liozon. A scholar is included among the top collaborators of É. Liozon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with É. Liozon. É. Liozon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ly, K.H., G. Gondran, H. Bézanahary, et al.. (2024). Upper respiratory tract and orofacial manifestations of new-onset giant cell arteritis: results from a large, prospective inception cohort study. Clinical and Experimental Rheumatology. 43(4). 611–620. 1 indexed citations
2.
3.
Feuillet, Fanny, É. Liozon, Maxime Samson, et al.. (2023). Giant cell arteritis associated with scalp, tongue or lip necrosis: A French multicenter case control study. Seminars in Arthritis and Rheumatism. 64. 152348–152348. 3 indexed citations
4.
Espitia, Olivier, Melanie C. Bois, Matthew J. Koster, et al.. (2022). Relationship between histopathological features of non-infectious aortitis and the results of pre-operative 18F-FDG-PET/CT: a retrospective study of 16 patients. Clinical and Experimental Rheumatology. 41(4). 916–921. 5 indexed citations
5.
Liozon, É., et al.. (2022). Immune-Mediated Diseases Following COVID-19 Vaccination: Report of a Teaching Hospital-Based Case-Series. Journal of Clinical Medicine. 11(24). 7484–7484. 5 indexed citations
6.
7.
Didier, Kévin, C. Paul, É. Liozon, et al.. (2022). IgA Vasculitis Following COVID-19 Vaccination: A French Multicenter Case Series Including 12 Patients. The Journal of Rheumatology. 50(2). 252–257. 5 indexed citations
8.
Boysson, Hubert de, Olivier Espitia, É. Liozon, et al.. (2019). Vascular Presentation and Outcomes of Patients With Giant Cell Arteritis and Isolated Symptomatic Limb Involvement. JCR Journal of Clinical Rheumatology. 26(6). 248–254. 3 indexed citations
9.
Samson, Maxime, H. Devilliers, K.H. Ly, et al.. (2018). Tocilizumab as an add-on therapy to glucocorticoids during the first 3 months of treatment of Giant cell arteritis: A prospective study. European Journal of Internal Medicine. 57. 96–104. 30 indexed citations
10.
Liozon, É., Hubert de Boysson, G. Gondran, et al.. (2018). Development of Giant Cell Arteritis after Treating Polymyalgia or Peripheral Arthritis: A Retrospective Case-control Study. The Journal of Rheumatology. 45(5). 678–685. 17 indexed citations
11.
Vignaud, Guillaume, É. Liozon, Laurent Magy, et al.. (2017). Contribution of dot-blot assay to the diagnosis and management of myositis: a three-year practice at a university hospital centre.. PubMed. 34(5). 918–924. 3 indexed citations
12.
Ly, K.H., É. Liozon, G. Gondran, et al.. (2016). Venous thrombosis in patients with giant cell arteritis: Features and outcomes in a cohort study. Joint Bone Spine. 84(3). 323–326. 8 indexed citations
13.
Grignano, Éric, A. Mékinian, Thorsten Braun, et al.. (2016). Autoimmune and inflammatory diseases associated with chronic myelomonocytic leukemia: A series of 26 cases and literature review. Leukemia Research. 47. 136–141. 36 indexed citations
14.
Ly, K.H., Jérôme Stirnemann, É. Liozon, et al.. (2013). Interleukin-1 blockade in refractory giant cell arteritis. Joint Bone Spine. 81(1). 76–78. 67 indexed citations
15.
Liozon, É., G. Gondran, K.H. Ly, V. Loustaud, & Elisabeth Vidal. (2008). Duration of Treatment After Eye Involvement in Giant Cell Arteritis. The Journal of Rheumatology. 35(6). 1220–1221. 3 indexed citations
16.
Liozon, É., François R. Herrmann, K.H. Ly, et al.. (2001). Facteurs prédictifs de complications céphaliques ischémiques irréversibles au cours de la maladie de Horton : étude prospective sur 178 patients. La Revue de Médecine Interne. 22(1). 30–41. 5 indexed citations
17.
Sparsa, A., V. Loustaud‐Ratti, É. Liozon, et al.. (2000). Syndrome d’hypersensibilité médicamenteuse en pratique interniste : pièges diagnostique et thérapeutique.Huit observations. La Revue de Médecine Interne. 21(12). 1052–1059. 10 indexed citations
18.
Brigaudeau, Christophe, et al.. (1996). Deletion of chromosome 20q associated with hypereosinophilic syndrome. Cancer Genetics and Cytogenetics. 87(1). 82–84. 10 indexed citations
19.
Liozon, É., et al.. (1995). AcSDKP serum concentrations vary during chemotherapy in patients with acute myeloid leukaemia. British Journal of Haematology. 89(4). 917–920. 11 indexed citations
20.
Vallat, J. M., et al.. (1993). Neuropathies périphériques et hémopathies. La Revue de Médecine Interne. 14(9). 841–850. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Micki Klearman Breakdown of academic impact, for papers by Koichi Amano Breakdown of academic impact, for papers by Tomás R. Vázquez-Rodríguez Breakdown of academic impact, for papers by Katie Tuckwell Breakdown of academic impact, for papers by Sophie Dimonaco Breakdown of academic impact, for papers by Jolanta Dadonienė Breakdown of academic impact, for papers by Maria J. Lopez‐Diaz Breakdown of academic impact, for papers by Jiuliang Zhao Breakdown of academic impact, for papers by Jan Willem Cohen-Tervaert Breakdown of academic impact, for papers by E Mirapeix
Rankless by CCL
2026